← Back to all trials
Completed
NCT05970315
Priorities Aligned Deprescribing for Persons Living With Dementia and Their Caregiver
Conditions: Dementia
Sex: All
Ages: 55 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 98
Sponsor: The University of Texas Health Science Center, Houston
Location: The University of Texas Health Science Center at Houston Houston Texas
Summary
The purpose of this study is to compare patient priorities care (PPC) and usual care (UC) patients to identify differences in post-encounter medication changes, treatment burden (TBQ), and shared decision making in Older Patient Assessment of Chronic Illness Care (OPACIC), to understand PPC participant's sense-making and communication approaches related to deprescribing decisions in relation to the identified health priorities and to identify and categorize adverse drug withdrawal events (ADWEs)
Eligibility Criteria
Inclusion Criteria:
* Dementia listed as an active problem in the medical record, including Alzheimer's disease, vascular dementia, frontotemporal dementia, Parkinson's dementia, Lewy body disease.
* The functional assessment staging tool (FAST) score of 5 or lower (This will be established by the patient's clinician).
* 2 or more additional chronic conditions
* Takes 5 or more regular medications and
* A caregiver present during visits. Caregivers may include family members or unrelated caregivers and will be identified through chart review and confirmed by clinician, patient, and surrogate decision maker if necessary. Identified caregivers must be involved in decisions and care of People living with dementia (PLWD) and routinely attend clinic visits with patient
Exclusion Criteria:
* FAST score of 6 or more (This will be established by the patient's clinician).
* Significant hearing, vision, or advanced cognitive impairment that limits ability to participate in PPC encounters,
* Caregiver is unwilling or able to participate in visits, or
* Deemed ineligible by their Primary care physician (PCP)
Source: ClinicalTrials.gov (NCT05970315). StuddyBuddy aggregates publicly available trial information.